nodes	percent_of_prediction	percent_of_DWPC	metapath
Griseofulvin—Microtubule Inhibition—Paclitaxel—ovarian cancer	0.55	0.58	CiPCiCtD
Griseofulvin—Microtubule Inhibition—Docetaxel—ovarian cancer	0.398	0.42	CiPCiCtD
Griseofulvin—CYP3A4—Topotecan—ovarian cancer	0.00614	0.354	CbGbCtD
Griseofulvin—CYP3A4—Vinorelbine—ovarian cancer	0.00433	0.25	CbGbCtD
Griseofulvin—CYP3A4—Paclitaxel—ovarian cancer	0.00304	0.175	CbGbCtD
Griseofulvin—CYP3A4—Docetaxel—ovarian cancer	0.0022	0.127	CbGbCtD
Griseofulvin—CYP3A4—Doxorubicin—ovarian cancer	0.00164	0.0945	CbGbCtD
Griseofulvin—Nephrotic syndrome—Chlorambucil—ovarian cancer	0.00149	0.0435	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Altretamine—ovarian cancer	0.00111	0.0324	CcSEcCtD
Griseofulvin—Leukopenia—Altretamine—ovarian cancer	0.000795	0.0231	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Topotecan—ovarian cancer	0.000707	0.0206	CcSEcCtD
Griseofulvin—Systemic lupus erythematosus—Paclitaxel—ovarian cancer	0.000668	0.0194	CcSEcCtD
Griseofulvin—Fatigue—Altretamine—ovarian cancer	0.000625	0.0182	CcSEcCtD
Griseofulvin—Neuropathy—Topotecan—ovarian cancer	0.000604	0.0176	CcSEcCtD
Griseofulvin—Neuropathy—Melphalan—ovarian cancer	0.000591	0.0172	CcSEcCtD
Griseofulvin—Oral candidiasis—Paclitaxel—ovarian cancer	0.000582	0.0169	CcSEcCtD
Griseofulvin—Systemic lupus erythematosus—Docetaxel—ovarian cancer	0.000566	0.0165	CcSEcCtD
Griseofulvin—Asthenia—Altretamine—ovarian cancer	0.00052	0.0151	CcSEcCtD
Griseofulvin—Oral candidiasis—Docetaxel—ovarian cancer	0.000494	0.0144	CcSEcCtD
Griseofulvin—Dizziness—Altretamine—ovarian cancer	0.000479	0.0139	CcSEcCtD
Griseofulvin—Vomiting—Altretamine—ovarian cancer	0.000461	0.0134	CcSEcCtD
Griseofulvin—Nausea—Altretamine—ovarian cancer	0.000431	0.0125	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Paclitaxel—ovarian cancer	0.000407	0.0118	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.000396	0.0115	CcSEcCtD
Griseofulvin—Candida infection—Paclitaxel—ovarian cancer	0.000353	0.0103	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Topotecan—ovarian cancer	0.000353	0.0103	CcSEcCtD
Griseofulvin—Neuropathy—Paclitaxel—ovarian cancer	0.000347	0.0101	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Melphalan—ovarian cancer	0.000345	0.01	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Docetaxel—ovarian cancer	0.000345	0.01	CcSEcCtD
Griseofulvin—Erythema multiforme—Chlorambucil—ovarian cancer	0.000343	0.00997	CcSEcCtD
Griseofulvin—Oral candidiasis—Epirubicin—ovarian cancer	0.000333	0.00968	CcSEcCtD
Griseofulvin—Hepatitis—Melphalan—ovarian cancer	0.000316	0.00919	CcSEcCtD
Griseofulvin—Oral candidiasis—Doxorubicin—ovarian cancer	0.000308	0.00896	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.000302	0.00877	CcSEcCtD
Griseofulvin—Candida infection—Docetaxel—ovarian cancer	0.000299	0.00871	CcSEcCtD
Griseofulvin—Neuropathy—Docetaxel—ovarian cancer	0.000294	0.00856	CcSEcCtD
Griseofulvin—Angioedema—Chlorambucil—ovarian cancer	0.000289	0.00839	CcSEcCtD
Griseofulvin—Agranulocytosis—Vinorelbine—ovarian cancer	0.000287	0.00835	CcSEcCtD
Griseofulvin—Leukopenia—Chlorambucil—ovarian cancer	0.000283	0.00822	CcSEcCtD
Griseofulvin—Confusional state—Chlorambucil—ovarian cancer	0.00026	0.00756	CcSEcCtD
Griseofulvin—Angioedema—Topotecan—ovarian cancer	0.000257	0.00747	CcSEcCtD
Griseofulvin—Leukopenia—Topotecan—ovarian cancer	0.000252	0.00732	CcSEcCtD
Griseofulvin—Leukopenia—Melphalan—ovarian cancer	0.000246	0.00716	CcSEcCtD
Griseofulvin—Erythema—Vinorelbine—ovarian cancer	0.00024	0.00699	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Epirubicin—ovarian cancer	0.000233	0.00676	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.000228	0.00662	CcSEcCtD
Griseofulvin—Dyspepsia—Chlorambucil—ovarian cancer	0.000227	0.0066	CcSEcCtD
Griseofulvin—Fatigue—Chlorambucil—ovarian cancer	0.000222	0.00646	CcSEcCtD
Griseofulvin—Angioedema—Vinorelbine—ovarian cancer	0.00022	0.00639	CcSEcCtD
Griseofulvin—Leukopenia—Vinorelbine—ovarian cancer	0.000215	0.00626	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Doxorubicin—ovarian cancer	0.000215	0.00626	CcSEcCtD
Griseofulvin—Feeling abnormal—Chlorambucil—ovarian cancer	0.000212	0.00618	CcSEcCtD
Griseofulvin—Paraesthesia—Topotecan—ovarian cancer	0.000206	0.00599	CcSEcCtD
Griseofulvin—Urticaria—Chlorambucil—ovarian cancer	0.000205	0.00595	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.000203	0.0059	CcSEcCtD
Griseofulvin—Candida infection—Epirubicin—ovarian cancer	0.000202	0.00587	CcSEcCtD
Griseofulvin—Dyspepsia—Topotecan—ovarian cancer	0.000202	0.00587	CcSEcCtD
Griseofulvin—Paraesthesia—Melphalan—ovarian cancer	0.000202	0.00587	CcSEcCtD
Griseofulvin—Neuropathy—Epirubicin—ovarian cancer	0.000199	0.00577	CcSEcCtD
Griseofulvin—Fatigue—Topotecan—ovarian cancer	0.000198	0.00575	CcSEcCtD
Griseofulvin—Dyspepsia—Melphalan—ovarian cancer	0.000198	0.00575	CcSEcCtD
Griseofulvin—Fatigue—Melphalan—ovarian cancer	0.000194	0.00563	CcSEcCtD
Griseofulvin—Hypersensitivity—Chlorambucil—ovarian cancer	0.00019	0.00552	CcSEcCtD
Griseofulvin—Feeling abnormal—Topotecan—ovarian cancer	0.000189	0.0055	CcSEcCtD
Griseofulvin—Candida infection—Doxorubicin—ovarian cancer	0.000187	0.00543	CcSEcCtD
Griseofulvin—Asthenia—Chlorambucil—ovarian cancer	0.000185	0.00538	CcSEcCtD
Griseofulvin—Neuropathy—Doxorubicin—ovarian cancer	0.000184	0.00534	CcSEcCtD
Griseofulvin—Urticaria—Topotecan—ovarian cancer	0.000182	0.0053	CcSEcCtD
Griseofulvin—Urticaria—Melphalan—ovarian cancer	0.000178	0.00519	CcSEcCtD
Griseofulvin—Diarrhoea—Chlorambucil—ovarian cancer	0.000176	0.00513	CcSEcCtD
Griseofulvin—Paraesthesia—Vinorelbine—ovarian cancer	0.000176	0.00512	CcSEcCtD
Griseofulvin—Erythema multiforme—Paclitaxel—ovarian cancer	0.000176	0.00511	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000172	0.005	CcSEcCtD
Griseofulvin—Fatigue—Vinorelbine—ovarian cancer	0.000169	0.00492	CcSEcCtD
Griseofulvin—Hypersensitivity—Topotecan—ovarian cancer	0.000169	0.00491	CcSEcCtD
Griseofulvin—Hypersensitivity—Melphalan—ovarian cancer	0.000165	0.00481	CcSEcCtD
Griseofulvin—Asthenia—Topotecan—ovarian cancer	0.000165	0.00479	CcSEcCtD
Griseofulvin—Vomiting—Chlorambucil—ovarian cancer	0.000164	0.00476	CcSEcCtD
Griseofulvin—Agranulocytosis—Docetaxel—ovarian cancer	0.000164	0.00476	CcSEcCtD
Griseofulvin—Erythema—Paclitaxel—ovarian cancer	0.000162	0.0047	CcSEcCtD
Griseofulvin—Feeling abnormal—Vinorelbine—ovarian cancer	0.000162	0.0047	CcSEcCtD
Griseofulvin—Asthenia—Melphalan—ovarian cancer	0.000161	0.00469	CcSEcCtD
Griseofulvin—Hepatitis—Docetaxel—ovarian cancer	0.000157	0.00458	CcSEcCtD
Griseofulvin—Diarrhoea—Topotecan—ovarian cancer	0.000157	0.00456	CcSEcCtD
Griseofulvin—Urticaria—Vinorelbine—ovarian cancer	0.000156	0.00453	CcSEcCtD
Griseofulvin—Diarrhoea—Melphalan—ovarian cancer	0.000154	0.00447	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000154	0.00446	CcSEcCtD
Griseofulvin—Nausea—Chlorambucil—ovarian cancer	0.000153	0.00445	CcSEcCtD
Griseofulvin—Dizziness—Topotecan—ovarian cancer	0.000152	0.00441	CcSEcCtD
Griseofulvin—Erythema multiforme—Docetaxel—ovarian cancer	0.000149	0.00433	CcSEcCtD
Griseofulvin—Angioedema—Paclitaxel—ovarian cancer	0.000148	0.0043	CcSEcCtD
Griseofulvin—Vomiting—Topotecan—ovarian cancer	0.000146	0.00424	CcSEcCtD
Griseofulvin—Leukopenia—Paclitaxel—ovarian cancer	0.000145	0.00421	CcSEcCtD
Griseofulvin—Rash—Topotecan—ovarian cancer	0.000145	0.00421	CcSEcCtD
Griseofulvin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000145	0.0042	CcSEcCtD
Griseofulvin—Dermatitis—Topotecan—ovarian cancer	0.000145	0.0042	CcSEcCtD
Griseofulvin—Headache—Topotecan—ovarian cancer	0.000144	0.00418	CcSEcCtD
Griseofulvin—Vomiting—Melphalan—ovarian cancer	0.000143	0.00415	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000142	0.00413	CcSEcCtD
Griseofulvin—Rash—Melphalan—ovarian cancer	0.000142	0.00412	CcSEcCtD
Griseofulvin—Dermatitis—Melphalan—ovarian cancer	0.000141	0.00411	CcSEcCtD
Griseofulvin—Asthenia—Vinorelbine—ovarian cancer	0.000141	0.00409	CcSEcCtD
Griseofulvin—Erythema—Docetaxel—ovarian cancer	0.000137	0.00399	CcSEcCtD
Griseofulvin—Nausea—Topotecan—ovarian cancer	0.000136	0.00396	CcSEcCtD
Griseofulvin—Diarrhoea—Vinorelbine—ovarian cancer	0.000134	0.0039	CcSEcCtD
Griseofulvin—Nausea—Melphalan—ovarian cancer	0.000133	0.00388	CcSEcCtD
Griseofulvin—Confusional state—Paclitaxel—ovarian cancer	0.000133	0.00387	CcSEcCtD
Griseofulvin—Dizziness—Vinorelbine—ovarian cancer	0.00013	0.00377	CcSEcCtD
Griseofulvin—Vomiting—Vinorelbine—ovarian cancer	0.000125	0.00363	CcSEcCtD
Griseofulvin—Rash—Vinorelbine—ovarian cancer	0.000124	0.0036	CcSEcCtD
Griseofulvin—Dermatitis—Vinorelbine—ovarian cancer	0.000124	0.00359	CcSEcCtD
Griseofulvin—Headache—Vinorelbine—ovarian cancer	0.000123	0.00358	CcSEcCtD
Griseofulvin—Leukopenia—Docetaxel—ovarian cancer	0.000123	0.00357	CcSEcCtD
Griseofulvin—Insomnia—Paclitaxel—ovarian cancer	0.000119	0.00347	CcSEcCtD
Griseofulvin—Paraesthesia—Paclitaxel—ovarian cancer	0.000119	0.00345	CcSEcCtD
Griseofulvin—Nausea—Vinorelbine—ovarian cancer	0.000117	0.00339	CcSEcCtD
Griseofulvin—Dyspepsia—Paclitaxel—ovarian cancer	0.000116	0.00338	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000116	0.00337	CcSEcCtD
Griseofulvin—Fatigue—Paclitaxel—ovarian cancer	0.000114	0.00331	CcSEcCtD
Griseofulvin—Confusional state—Docetaxel—ovarian cancer	0.000113	0.00328	CcSEcCtD
Griseofulvin—Agranulocytosis—Epirubicin—ovarian cancer	0.00011	0.00321	CcSEcCtD
Griseofulvin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000109	0.00316	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000107	0.00312	CcSEcCtD
Griseofulvin—Hepatitis—Epirubicin—ovarian cancer	0.000106	0.00309	CcSEcCtD
Griseofulvin—Urticaria—Paclitaxel—ovarian cancer	0.000105	0.00305	CcSEcCtD
Griseofulvin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000102	0.00297	CcSEcCtD
Griseofulvin—Insomnia—Docetaxel—ovarian cancer	0.000101	0.00294	CcSEcCtD
Griseofulvin—Paraesthesia—Docetaxel—ovarian cancer	0.0001	0.00292	CcSEcCtD
Griseofulvin—Erythema multiforme—Epirubicin—ovarian cancer	0.0001	0.00292	CcSEcCtD
Griseofulvin—Dyspepsia—Docetaxel—ovarian cancer	9.85e-05	0.00286	CcSEcCtD
Griseofulvin—Hepatitis—Doxorubicin—ovarian cancer	9.83e-05	0.00286	CcSEcCtD
Griseofulvin—Hypersensitivity—Paclitaxel—ovarian cancer	9.72e-05	0.00283	CcSEcCtD
Griseofulvin—Fatigue—Docetaxel—ovarian cancer	9.65e-05	0.0028	CcSEcCtD
Griseofulvin—Asthenia—Paclitaxel—ovarian cancer	9.47e-05	0.00275	CcSEcCtD
Griseofulvin—Erythema multiforme—Doxorubicin—ovarian cancer	9.29e-05	0.0027	CcSEcCtD
Griseofulvin—Erythema—Epirubicin—ovarian cancer	9.25e-05	0.00269	CcSEcCtD
Griseofulvin—Feeling abnormal—Docetaxel—ovarian cancer	9.22e-05	0.00268	CcSEcCtD
Griseofulvin—Diarrhoea—Paclitaxel—ovarian cancer	9.03e-05	0.00263	CcSEcCtD
Griseofulvin—Dizziness—Paclitaxel—ovarian cancer	8.73e-05	0.00254	CcSEcCtD
Griseofulvin—Erythema—Doxorubicin—ovarian cancer	8.56e-05	0.00249	CcSEcCtD
Griseofulvin—Vomiting—Paclitaxel—ovarian cancer	8.39e-05	0.00244	CcSEcCtD
Griseofulvin—Rash—Paclitaxel—ovarian cancer	8.32e-05	0.00242	CcSEcCtD
Griseofulvin—Dermatitis—Paclitaxel—ovarian cancer	8.31e-05	0.00242	CcSEcCtD
Griseofulvin—Leukopenia—Epirubicin—ovarian cancer	8.28e-05	0.00241	CcSEcCtD
Griseofulvin—Headache—Paclitaxel—ovarian cancer	8.27e-05	0.0024	CcSEcCtD
Griseofulvin—Hypersensitivity—Docetaxel—ovarian cancer	8.24e-05	0.0024	CcSEcCtD
Griseofulvin—Asthenia—Docetaxel—ovarian cancer	8.03e-05	0.00233	CcSEcCtD
Griseofulvin—Nausea—Paclitaxel—ovarian cancer	7.84e-05	0.00228	CcSEcCtD
Griseofulvin—Leukopenia—Doxorubicin—ovarian cancer	7.66e-05	0.00223	CcSEcCtD
Griseofulvin—Diarrhoea—Docetaxel—ovarian cancer	7.65e-05	0.00223	CcSEcCtD
Griseofulvin—Confusional state—Epirubicin—ovarian cancer	7.61e-05	0.00221	CcSEcCtD
Griseofulvin—Dizziness—Docetaxel—ovarian cancer	7.4e-05	0.00215	CcSEcCtD
Griseofulvin—Vomiting—Docetaxel—ovarian cancer	7.11e-05	0.00207	CcSEcCtD
Griseofulvin—Rash—Docetaxel—ovarian cancer	7.05e-05	0.00205	CcSEcCtD
Griseofulvin—Dermatitis—Docetaxel—ovarian cancer	7.05e-05	0.00205	CcSEcCtD
Griseofulvin—Confusional state—Doxorubicin—ovarian cancer	7.04e-05	0.00205	CcSEcCtD
Griseofulvin—Headache—Docetaxel—ovarian cancer	7.01e-05	0.00204	CcSEcCtD
Griseofulvin—Insomnia—Epirubicin—ovarian cancer	6.83e-05	0.00198	CcSEcCtD
Griseofulvin—Paraesthesia—Epirubicin—ovarian cancer	6.78e-05	0.00197	CcSEcCtD
Griseofulvin—Nausea—Docetaxel—ovarian cancer	6.65e-05	0.00193	CcSEcCtD
Griseofulvin—Dyspepsia—Epirubicin—ovarian cancer	6.64e-05	0.00193	CcSEcCtD
Griseofulvin—Fatigue—Epirubicin—ovarian cancer	6.51e-05	0.00189	CcSEcCtD
Griseofulvin—Insomnia—Doxorubicin—ovarian cancer	6.32e-05	0.00184	CcSEcCtD
Griseofulvin—Paraesthesia—Doxorubicin—ovarian cancer	6.27e-05	0.00182	CcSEcCtD
Griseofulvin—Feeling abnormal—Epirubicin—ovarian cancer	6.22e-05	0.00181	CcSEcCtD
Griseofulvin—Dyspepsia—Doxorubicin—ovarian cancer	6.15e-05	0.00179	CcSEcCtD
Griseofulvin—Fatigue—Doxorubicin—ovarian cancer	6.02e-05	0.00175	CcSEcCtD
Griseofulvin—Urticaria—Epirubicin—ovarian cancer	5.99e-05	0.00174	CcSEcCtD
Griseofulvin—Feeling abnormal—Doxorubicin—ovarian cancer	5.75e-05	0.00167	CcSEcCtD
Griseofulvin—Hypersensitivity—Epirubicin—ovarian cancer	5.56e-05	0.00162	CcSEcCtD
Griseofulvin—Urticaria—Doxorubicin—ovarian cancer	5.55e-05	0.00161	CcSEcCtD
Griseofulvin—Asthenia—Epirubicin—ovarian cancer	5.41e-05	0.00157	CcSEcCtD
Griseofulvin—Diarrhoea—Epirubicin—ovarian cancer	5.16e-05	0.0015	CcSEcCtD
Griseofulvin—Hypersensitivity—Doxorubicin—ovarian cancer	5.14e-05	0.0015	CcSEcCtD
Griseofulvin—Asthenia—Doxorubicin—ovarian cancer	5.01e-05	0.00146	CcSEcCtD
Griseofulvin—Dizziness—Epirubicin—ovarian cancer	4.99e-05	0.00145	CcSEcCtD
Griseofulvin—Vomiting—Epirubicin—ovarian cancer	4.8e-05	0.0014	CcSEcCtD
Griseofulvin—Diarrhoea—Doxorubicin—ovarian cancer	4.78e-05	0.00139	CcSEcCtD
Griseofulvin—Rash—Epirubicin—ovarian cancer	4.76e-05	0.00138	CcSEcCtD
Griseofulvin—Dermatitis—Epirubicin—ovarian cancer	4.75e-05	0.00138	CcSEcCtD
Griseofulvin—Headache—Epirubicin—ovarian cancer	4.73e-05	0.00137	CcSEcCtD
Griseofulvin—Dizziness—Doxorubicin—ovarian cancer	4.62e-05	0.00134	CcSEcCtD
Griseofulvin—Nausea—Epirubicin—ovarian cancer	4.48e-05	0.0013	CcSEcCtD
Griseofulvin—Vomiting—Doxorubicin—ovarian cancer	4.44e-05	0.00129	CcSEcCtD
Griseofulvin—Rash—Doxorubicin—ovarian cancer	4.4e-05	0.00128	CcSEcCtD
Griseofulvin—Dermatitis—Doxorubicin—ovarian cancer	4.4e-05	0.00128	CcSEcCtD
Griseofulvin—Headache—Doxorubicin—ovarian cancer	4.37e-05	0.00127	CcSEcCtD
Griseofulvin—Nausea—Doxorubicin—ovarian cancer	4.15e-05	0.00121	CcSEcCtD
